Provides equipment for operating rooms and intensive-care units. Offers sterilization solutions for healthcare facilities. Now — the numbers.
The stock trades 50% below its peak. The market has trimmed its expectations for the company.
It pays out $0.51 per share each year — regular cash for whoever holds the stock.
Since the drop from its peak, buyer appetite hasn’t come back.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: revenue and profit, the growth trend, the balance sheet, earnings execution, the revenue breakdown.